Navigation Links
AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results
Date:3/24/2011

REDWOOD CITY, Calif., March 24, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute or breakthrough pain, today reported financial results for the fourth quarter and year ended December 31, 2010.

Net loss for the fourth quarter of 2010 was $3.5 million, or $5.23 per common share, compared with a net loss of $3.7 million, or $6.05 per common share, for the fourth quarter of 2009. Net loss for the year ended December 31, 2010 was $14.3 million, or $21.84 per common share, compared to a net loss of $20.1 million, or $34.93 per common share, for the year ended December 31, 2009.

Research and development expenses for the twelve and three months ended December 31, 2010 totaled $8.2 million and $1.9 million, compared to $15.5 million and $2.3 million for the twelve and three months ended December 31, 2009. General and administrative expenses were $4.0 million and $1.0 million for the year and quarter ended December 31, 2010, compared to $3.5 million and $1.0 million for the year and quarter ended December 31, 2009.

As of December 31, 2010, AcelRx had cash, cash equivalents and short-term investments of $3.7 million, compared to $12.5 million as of December 31, 2009. On February 16, 2011, AcelRx closed its initial public offering of 8.0 million shares of common stock resulting in net proceeds to AcelRx of $35.6 million.  We intend to utilize these funds primarily for advancement of our lead program, our hospital-based, patient-controlled analgesia (PCA) product, the Sufentanil NanoTab PCA System (ARX-01).

"We are pleased with our progress towards initiating the Phase 3 program for ARX-01 in acute post-operative pain," said Richard King, President and Chief Executive Officer of AcelRx. "We anticipate
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AcelRx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
2. AcelRx Pharmaceuticals Announces Pricing of Its Initial Public Offering
3. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
4. AcelRx Announces Positive Phase 2 Results From a Study of ARX-02 Sufentanil NanoTab(TM) Breakthrough Pain Management System in Treating Cancer Breakthrough Pain
5. AcelRx to Present at the Lazard 6th Annual Healthcare Conference
6. AcelRx Programs to be Featured in Oral Presentations at the American Society of Anesthesiologists 2009 Annual Meeting
7. AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
8. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
9. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
10. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , November 26, 2014 A ... of the organ protrudes through the wall of a weak ... area at birth are some of the causes of hernias. ... hiatal, femoral, and incisional. An inguinal hernia is when part ... umbilical hernia is found in the area of the umbilicus. ...
(Date:11/26/2014)... , Nov. 26, 2014  Aridis Pharmaceuticals, ... produce novel therapies for infectious diseases, announced today ... an internationally recognized key opinion leader in the ... scientific advisory board. Founder and Chief ... "We believe Dr. Opal,s extensive experience investigating bacterial ...
(Date:11/26/2014)... 25, 2014 According to ... Power Source (Electric, Battery, Pneumatic), by Product (Drill, ... Cart), by Application (Orthopedic, ENT, Oral, Thoracic, Neurology) ... global Powered Surgical Instruments Market is estimated to ... 2014 and is expected to grow at a ...
Breaking Medicine Technology:Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4
... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced ... the Citi 2012 Global Health Care Conference on Wednesday, February ... Time) at the Waldorf=Astoria in New York City. Jack Lief, ... a corporate overview. A live audio webcast of ...
... Switzerland, Feb. 23, 2012  Auxilium Pharmaceuticals, Inc. ... Pharmaceuticals Ltd. (SWX: ATLN.S) announced today that ... for the development, supply and commercialization of ... biologic for the potential treatment of Dupuytren,s ...
Cached Medicine Technology:Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 2Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 3Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico 2Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico 3Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico 4Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico 5Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico 6
(Date:11/28/2014)... 2014 Written and narrated by award winning ... releases the “The Happiest Man In the World: Life ... of how and why Project C.U.R.E. came to be. , ... Josie and the Reverend Richard W. Jackson, Dr. Jackson exceeded ... 30, but realized that he wasn’t happy. Prompted by this ...
(Date:11/28/2014)... Austin, Texas (PRWEB) November 28, 2014 ... of prediabetes testing and treatment, helped employees learn ... complimentary on-site diabetes blood screening at a local ... Stop Diabetes @ Work initiative. , As ... @ Work program , PreDiabetes Centers is co-hosting ...
(Date:11/28/2014)... Everett, WA (PRWEB) November 28, 2014 ... Snohomish County provides an overview of the influenza virus that ... annual flu season. , The article begins with a ... it manifests its symptoms. It reminds families that children under ... and those suffering from chronic diseases, such as heart and ...
(Date:11/28/2014)... 28, 2014 An inventor from Flint, Mich., ... day. "I got this idea while lying in a hospital ... he said. , The Bed Buddy provides a more ergonomic ... the bathroom. It eliminates the need to leave the bed, ... and dignity. Easy to use and producible in design variations, ...
(Date:11/28/2014)... Most of the people attending a presentation by Ken ... Prince Woods retirement community found out the “prized” possessions ... wouldn’t have made the cut to be on an “Antiques ... decorative and folk art and his appearances on the PBS ... buying and selling antiques. Broadly speaking the antiques market ...
Breaking Medicine News(10 mins):Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2Health News:Antiques Appraiser Sheds Light on "Treasures" 2
... AlertSite(R), a leading,provider of web site performance ... for their customers, announced today that,iHerb.com has chosen ... a major online retailer of brand name nutritional ... ConsumerLab.com as the #1 Online,Supplement Retailer, based on ...
... NEW YORK, Feb. 26 "It is not ... water outweigh risks of,neurodevelopment or other effects such ... Environmental Health report.(1), Fluoride chemicals are added ... reduce tooth decay. Fluoride is found in dental ...
... Feb. 26 With over five million Americans,suffering from ... cases,diagnosed every year, it is the number one cause ... a yearly direct cost of care,estimated at $100 billion, ... Device Markets., Improvements in the care of other ...
... About Medicare, Health Insurance Options, KANSAS CITY, ... boomers turn 62 this year and begin claiming ... the National Association of Insurance,Commissioners (NAIC), many are ... Medicare eligibility., The NAIC,s national survey of ...
... offers a breakthrough in advancing, apoptosis-related research ... medicine, ST. LOUIS, Feb. 26 Sigma-Aldrich(TM) ... that they,have signed a licensing agreement for a ... apoptosis in vitro and in vivo in animals. ...
... Income from Operations, LOVELAND, Colo., Feb. 26 Heska ... fourth quarter, the,three months ended December 31, 2007, and year ... ), Heska Corporation ("Heska" or the "Company") highlights for ... - the highest total revenue in Heska ...
Cached Medicine News:Health News:Top Nutritional Supplement Online Retailer, iHerb.com, Selects AlertSite for Web Site Performance Monitoring 2Health News:Fluoride May Damage the Brain, New Report Says 2Health News:'Hidden Epidemic' of Congestive Heart Failure Driving Hospitalization, Costs 2Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 2Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 3Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 4Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 5Health News:Baby Boomers Confused About Medicare, According to Recent NAIC Survey 6Health News:Sigma-Aldrich Licenses From NeuroSurvival Technologies a Leading Marker for Molecular Imaging of Apoptosis in Vivo 2Health News:Sigma-Aldrich Licenses From NeuroSurvival Technologies a Leading Marker for Molecular Imaging of Apoptosis in Vivo 3Health News:Heska Announces Q4 and Annual 2007 Results 2Health News:Heska Announces Q4 and Annual 2007 Results 3Health News:Heska Announces Q4 and Annual 2007 Results 4Health News:Heska Announces Q4 and Annual 2007 Results 5Health News:Heska Announces Q4 and Annual 2007 Results 6Health News:Heska Announces Q4 and Annual 2007 Results 7Health News:Heska Announces Q4 and Annual 2007 Results 8Health News:Heska Announces Q4 and Annual 2007 Results 9Health News:Heska Announces Q4 and Annual 2007 Results 10
These are the Reusable Components (minus cannula), to be used with the VersaStep™ Plus Reposable Short System....
The VersaStep™ 5 mm and VersaStep™ PLUS Reposable system components for creating each access port are supplied in separate packages....
VersaStep™ Reposable Sterilization Trays....
... Instrument for applications in ... ,The VERSASTEP™ Plus instrument ... length is a unique ... radial dilation. It is ...
Medicine Products: